ClinicalTrials.gg
CompletedNCT03833947Updated Jan 3, 2020

Dexamethasone vs Bicarbonate to Intracuff Lignocaine 2% in General Anaesthesia

A Phase 4 interventional study of lignocaine+bicarbonate and lignocaine+dexamethasone in Anesthesia, Anesthesia; Adverse Effect and Anesthesia Intubation Complication, sponsored by Aligarh Muslim University. Completed at 1 site in India. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-01-03.

Sponsored by Aligarh Muslim University · Phase 4, Interventional, and Supportive care

Phase
Phase 4
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

This study is designed to evaluate and compare the effect on hemodynamics, extubation response and patients satisfaction score in patients with ETT cuff filled with either mixture of lignocaine with sodium bicarbonate or with a mixture of lignocaine with dexamethasone.

Read the detailed description

Objective Recently multiple studies have shown better outcomes with usage of dexamethasone or alkalinized lignocaine instead of air for filling endotracheal tube (ETT) cuff. So this study is designed to evaluate and compare the effect on hemodynamics, extubation response and patients satisfaction score in patients with ETT cuff filled with either mixture of lignocaine with sodium bicarbonate or with a mixture of lignocaine with dexamethasone.

Design and setting:

This is a prospective single blind, randomized controlled study at the department of anesthesiology, JNMCH, AMU, Aligarh.

Materials and methods:

Investigators plan to include 100 patients of age group within 18-60 years with American Society of Anesthesiologists (ASA) class I \& II, posted for elective surgery of duration >120 minutes, performed under general anesthesia; administered as per institutional protocols. Patients with ASA III \& IV, cardiovascular morbidities, known drug allergy, pregnancy will be excluded from the study. Patients will be divided into two groups randomly according to chit-in-box method, viz Group A \& Group D with fifty patients in each group. Patient group allocation, preparation of drug mixture for endotracheal cuff filling as per group assigned and analysis of observed data will be done by a separate anesthetist not involved in the perioperative management of the patient. In patients belonging to Group (A), ETT cuff will be filled with mixture of 7.5% sodium bicarbonate with 2% lignocaine in the proportions of 0.5: 9.5 ml while in Group D the ETT cuff will be filled with mixture of dexamethasone with 2% lignocaine in the proportions of 0.5: 9.5 ml . The cuff of the ETT will be slowly inflated until no leak is heard at all during the peak airway pressure of the ventilator cycle while auscultating the trachea . Volume of drug mixture in the cuff will be noted at start and end of surgery. Total duration of anesthesia will be noted.

Hemodynamic stability at the time of extubation will be meausred in terms of changes in rate pressure product (RPP) which will denote the product of heart rate and systolic blood pressure. RPP values recorded immediately after stoppage of the anesthetic agents at the end of surgery will be compared to the values measured just after the extubation of trachea. Patient's satisfaction from anesthesia given will be recorded, based on VAS. The presence of coughing and bucking will also be noted. Incidence of postoperative sore throat and cough will be recorded at 1 hour and 24 hours post extubation.

The results will be presented in number, percentage, mean, and standard deviation as appropriate. Appropriate statistical tests will be applied and P value less than 0.05 will be considered as statistically significant.

02

Conditions studied

  • Anesthesia
  • Anesthesia; Adverse Effect
  • Anesthesia Intubation Complication

Keywords

  • Intracuff Dexamethasone
  • Intracuff Alkalinized lignocaine
  • General anesthesia
03

In context

Lead sponsor

Aligarh Muslim University is the lead sponsor of 7 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • (ASA) class I \& II.
  • Elective surgery
  • General anesthesia of duration >120 minutes.

Exclusion criteria

Exclusion Criteria:

  • Patients with \& IV.
  • Known Cardiovascular morbidities.
  • Pregnancy.
  • Allergic to used drugs.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Phase 4
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Care provider)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    lignocaine with bicarbonate

    Endotracheal tube cuff was filled with mixture of 7.5% sodium bicarbonate with 2% lignocaine in a ratio of 0.5:9.5 ml

    Drug: lignocaine+bicarbonate

  • Active comparator
    lignocaine with dexamethasone

    Endotracheal tube cuff was filled with mixture of dexamethasone with 2% lignocaine in a ratio of 0.5:9.5 ml

    Drug: lignocaine+dexamethasone

Interventions

  • Druglignocaine+bicarbonate

    Drug pages: Lidocaine · Bicarbonates

    ETT cuff was filled with mixture of 2% lignocaine with bicarbonate

  • Druglignocaine+dexamethasone

    Drug pages: Lidocaine · Dexamethasone

    ETT cuff was filled with mixture of 2% lignocaine with dexamethasone

06

What researchers measure

Primary outcomes

  1. smoothness of extubation

    Grade 1= coughing, bucking, tube biting, agitatation present. Grade 2= mild bucking/coughing. Grade 3= completely comfortable, tolerating tube in situ, no coughing/bucking/agitation.

    Time frame: time from adequate reversal of anaesthesia & muscle paralysis (head holding >5sec, eye opening on command, train of four ratio >0.9) till removal of endotracheal tube.

  2. patient satisfaction score

    rated on visual analog scale varying 0 to 10; where 0 is worst experience and 10 is best. completely

    Time frame: post operative 1 hour

Secondary outcomes

  1. Haemodynamic stability at the time of extubation.

    Rate pressure product (RPP); \[RPP=Product of systolic blood pressure(mmHg) and heart rate (beats per min)\] measured after stopping the anaesthetic agents at the end of surgery will be taken as baseline and then compared to values measured immediately after the removal of endotracheal tube.

    Time frame: values of product of systolic blood pressure and heart rate will be compared after stopping the anesthetic agents and immediately after the extubation

  2. amount of drug diffused through endotracheal tube cuff

    Volume of drug mixture in the cuff was noted at start and end of surgery.

    Time frame: from start till end of surgery.

  3. incidence of post operative cough and sore throat

    incidence of post operative cough and sore throat

    Time frame: after 1 and 24 hour post extubation

Other outcomes

  1. duration of surgery

    duration of surgery

    Time frame: duration of surgery

07

Study locations

1 site
  • Jawaharlal Nehru Medical College
    Aligarh, Uttar Pradesh 450331, India
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 3, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03833947
Lead sponsor
Aligarh Muslim University
Responsible party
MUAZZAM HASAN (Assistant Professor, Department of Anaesthesiology, Aligarh Muslim University) — Principal investigator
First posted
Feb 7, 2019
Start date
Mar 15, 2019
Primary completion
Oct 30, 2019
Completion
Dec 30, 2019
Last update
Jan 3, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Lidocaine · Bicarbonates

Start the discussion